A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
Launched by ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST · Sep 13, 2010
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of a coronary artery stenosis undergoing percutaneous coronary intervention and stenting (PCI).
- • Eligibility for drug eluting stent (DES) deployment.
- • Stable or unstable coronary syndrome presentation, including ST elevation myocardial infarction (STEMI).
- • Aged 18-90
- Exclusion Criteria:
- • Contraindication to the use of a DES.
- • Target lesion located within previous stent (in stent restenosis).
- • Sustained haemodynamic instability following stent deployment (Systolic BP 90≤ mmHg or sustained ventricular arrhythmia).
About Royal Brompton & Harefield Nhs Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust is a leading specialist healthcare provider in the United Kingdom, renowned for its expertise in cardiothoracic medicine and respiratory care. Committed to advancing clinical research and improving patient outcomes, the Trust conducts a diverse range of clinical trials aimed at exploring innovative treatments and therapies. With a multidisciplinary team of clinicians and researchers, the Foundation Trust fosters a collaborative environment that prioritizes patient safety and ethical standards, contributing significantly to the global body of medical knowledge and enhancing the quality of care for patients with complex health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Harefield, Middlesex, United Kingdom
Patients applied
Trial Officials
Miles CD Dalby, MD, MRCP
Principal Investigator
Consultant Cardiologist, The Royal Brompton & Harefield NHS Foundation Trust
Robert D Smith, MD, MRCP
Study Director
The Royal Brompton & Harefield NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials